According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

Chronic illnesses and rare disorders among older Americans represent a rapidly intensifying challenge for the U.S. healthcare system, with the National Institutes of Health estimating that more than ...

Explore trends before investing – request a sample report today! A central growth driver for the Norway Aquaculture Vaccines Market is the nation’s strict sustainability standards, which prioritize ...

Quantum technology is accelerating out of the lab and into the real world, and a new article argues that the field now stands ...

New research published in Nature Communications has linked a normal cellular process to an accumulation of DNA mutations in ...

Researchers at The University of Texas MD Anderson Cancer Center have performed a comprehensive evaluation of five artificial ...

Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

The U.S. Active Pharmaceutical Ingredients (API) market is set to expand from $67.11 billion in 2024 to $117.86 billion by ...

Nobel laureate David Baker’s latest foundation model can design proteins that interact to any biomolecule for broad biotech applications.

Researchers created a highly efficient gene-editing method that fixes multiple DNA mutations in a single step. The breakthrough could revolutionize genetic medicine by making treatments for complex ...